Results 31 to 40 of about 111,089 (390)

Relationship between device acceptance and patient-reported outcomes in left ventricular assist device (LVAD) recipients [PDF]

open access: yes, 2019
The number of Left Ventricular Assist Devices (LVADs) implanted each year is rising. Nevertheless, there are minimal data on device acceptance after LVAD implant, and on its relationship with patient-reported outcomes. We designed a cross-sectional study
Adamo, Luigi   +7 more
core   +2 more sources

Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.

open access: yesInteractive Cardiovascular and Thoracic Surgery, 2020
OBJECTIVES Right heart failure after left ventricular assist device (LVAD) implantation is associated with significant morbidity and mortality. A new generation of percutaneous right ventricular assist devices (RVADs) may mitigate the need for invasive ...
M. Salna   +11 more
semanticscholar   +1 more source

Left Ventricular Assist Devices and the Kidney [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2017
Left ventricular assist devices (LVADs) are common and implantation carries risk of AKI. LVADs are used as a bridge to heart transplantation or as destination therapy. Patients with refractory heart failure that develop chronic cardiorenal syndrome and CKD often improve after LVAD placement. Nevertheless, reversibility of CKD is hard to predict.
Gerin R. Stevens   +7 more
openaire   +2 more sources

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)

open access: yesВестник трансплантологии и искусственных органов, 2023
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov   +4 more
doaj   +1 more source

Initial experience with the left ventricular assist device TransCoreTM [PDF]

open access: yes, 2010
Cardiogenic shock is a condition associated to high mortality rates. For decades, the treatment consisted of vasoactive drugs and intra-aortic balloon pump.
Alves, Claudia Maria Rodrigues   +3 more
core   +1 more source

Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study

open access: yesESC Heart Failure, 2020
Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist device (LVAD) occurs in approximately 1–2% of the cases. However, follow‐up data about this condition are scarcely available in the literature.
C. Antonides   +12 more
semanticscholar   +1 more source

Editorial: Management of right ventricular failure: pathophysiology, medical treatment and use of ventricular assist devices [PDF]

open access: yes, 2023
Left ventricular assist device; Advanced heart failure; Right ventricular failureDispositiu d'assistència ventricular esquerre; Insuficiència cardíaca avançada; Insuficiència del ventricle dretDispositivo de asistencia ventricular izquierda ...
Barrabés, José A.   +3 more
core   +1 more source

Left ventricular assist device.

open access: yesNew England Journal of Medicine, 2002
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel   +2 more
openaire   +4 more sources

Design and characteristics of the prophylactic intra‐operative ventricular arrhythmia ablation in high‐risk LVAD candidates (PIVATAL) trial

open access: yesAnnals of Noninvasive Electrocardiology, 2023
Background The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical
David T. Huang   +33 more
doaj   +1 more source

Extended right posterior liver sectionectomy for HCC in a patient with left ventricular assist device—a case report [PDF]

open access: yes, 2020
Successful implementation of left ventricular assist devices lead to a prolonged survival in patients with chronic terminal heart failure. Thus, patients with pre-existing left ventricular assist devices with abdominal comorbidities requiring abdominal ...
Lojewski, Christian   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy